Laura E. Niklason, President, CEO and Director at Humacyte, Inc. (HUMA), sold 400,000 shares at $9.80 ($3.7M) on 2021-12-14, disclosed to the SEC on 2021-12-16.
Open-market sale of $3.7M HUMA by President, CEO and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.33 | 76,306 | $712K | 19.4% |
| 2 | $9.33 | 76,306 | $712K | 19.4% |
| 3 | $9.80 | 23,694 | $232K | 6.3% |
| 4 | $9.80 | 23,694 | $232K | 6.3% |
| 5 | $8.89 | 125,000 | $1.1M | 30.2% |
| 6 | $9.00 | 75,000 |
| $675K |
| 18.4% |
| Total | $9.19 avg | 400,000 | $3.7M | 100% |
| Filing → |
| HUMA | SELL | 2024-11-20 | $13.2M | — | Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |